Immediate Impact
2 by Nobel laureates 2 from Science/Nature 53 standout
Citing Papers
Clinical applications of human organoids
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Thomas A. Longo being referenced
Atezolizumab: A PD-L1–Blocking Antibody for Bladder Cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas A. Longo | 178 | 85 | 172 | 23 | 408 | |
| Kota Iida | 223 | 103 | 157 | 38 | 421 | |
| Yoshitaka Itami | 181 | 91 | 168 | 38 | 388 | |
| A. Cooper | 122 | 67 | 133 | 25 | 368 | |
| Katrina McGinty | 135 | 69 | 112 | 20 | 345 | |
| John Papadopoulos | 91 | 122 | 101 | 17 | 357 | |
| Einar Brekkan | 121 | 166 | 75 | 20 | 367 | |
| Lata Raman | 59 | 99 | 100 | 20 | 431 | |
| T Kaku | 154 | 66 | 61 | 23 | 383 | |
| Jukka Kallio | 242 | 79 | 101 | 20 | 421 | |
| T Igarashi | 119 | 77 | 142 | 24 | 421 |
All Works
Loading papers...